Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

328

Participants

Timeline

Start Date

February 18, 2003

Primary Completion Date

January 27, 2004

Conditions
HIV Infections
Interventions
DRUG

tipranavir

DRUG

ritonavir

DRUG

saquinavir

DRUG

amprenavir

DRUG

lopinavir

Trial Locations (109)

Unknown

Boehringer Ingelheim Investigational Site, Phoenix

Boehringer Ingelheim Investigational Site, Berkeley

Boehringer Ingelheim Investigational Site, Fountain Valley

Boehringer Ingelheim Investigational Site, Los Angeles

Boehringer Ingelheim Investigational Site, San Francisco

Kaiser Permanente Medical Center, San Francisco

San Francisco VAMC, San Francisco

Boehringer Ingelheim Investigational Site, Norwalk

Washington DC VA Medical Center, Washington D.C.

North Broward Hospital District, Fort Lauderdale

Boehringer Ingelheim Investigational Site, Fort Myers

Boehringer Ingelheim Investigational Site, Miami

Boehringer Ingelheim Investigational Site, Orlando

Boehringer Ingelheim Investigational Site, Sarasota

Boehringer Ingelheim Investigational Site, Tampa

Boehringer Ingelheim Investigational Site, Vero Beach

Boehringer Ingelheim Investigational Site, Atlanta

Mercer University School of Medicine, Macon

University of Kentucky Medical Center, Lexington

Boehringer Ingelheim Investigational Site, Boston

Brigham and Women's Hospital, Boston

Boehringer Ingelheim Investigational Site, Springfield

Henry Ford Hospital, Detroit

Boehringer Ingelheim Investigational Site, Santa Fe

Albany Medical College, Albany

Boehringer Ingelheim Investigational Site, New York

University of New York, Stony Brook, Stony Brook

Duke University Medical Center, Durham

Boehringer Ingelheim Investigational Site, Huntersville

University of Pennsylvania, Philadelphia

UT Southwestern, Dallas

Boehringer Ingelheim Investigational Site, Houston

Boehringer Ingelheim Investigational Site, Annandale

Boehringer Ingelheim Investigational Site, Tacoma

Boehringer Ingelheim Investigational Site, Darlinghurst

St. Vincent's Hospital, Darlinghurst

Instituut Tropische Geneeskunde, Antwerp

Centre Hospitalier Universitaire St. Pierre, Brussels

U.Z. Gent, Ghent

McMaster University Medical Centre, Hamilton

Boehringer Ingelheim Investigational Site, Toronto

Canadian Immunodeficiency Research Collaborative Inc., Toronto

Toronto General Hospital, Toronto

McGill University Health Centre, Suite A5-140, Monteal

Boehringer Ingelheim Investigational Site, Montreal

Montreal Chest Institute - McGill University Health Centre, Montreal

Hvidovre Hospital, Hvidovre

Rigshospitalet, København Ø

Odense Universitetshospital, Odense C

Hôpital Pellegrin, Bordeaux

Hôpital Côte de Nacre, Caen

Hôpital Antoine Beclère, Clamart

Hôpital de l'Hôtel Dieu, Lyon

Hôpital Hôtel Dieu, Nantes

Hôpital de l'Archet, Nice

Hôpital Bichat Claude Bernard, Paris

Hôpital de la Pité Salpêtrière, Paris

Hôpital Européen Georges Pompidou, Paris

Hôpital Saint Antoine, Paris

Hôpital de Pontchaillou, Rennes

Hôpital civil, Strasbourg

Hôpital brabois, Vandœuvre-lès-Nancy

Hôpital Paul Brousse, Villejuif

Boehringer Ingelheim Investigational Site, Aachen

Epimed GmbH, Berlin

Universitätsklinikum Charité, Berlin

Medizinische Universitätsklinik Bonn, Bonn

Klinik I für Innere Medizin der, Cologne

Boehringer Ingelheim Investigational Site, Düsseldorf

Universitätsklinikum Düsseldorf, Düsseldorf

Universitätsklinik Erlangen-Nürnberg, Erlangen

Universitätsklinikum Essen, Essen

Klinikum der Johann Wolfgang Goethe-Universität, Frankfurt am Main

Boehringer Ingelheim Investigational Site, Freiburg im Breisgau

Universitätsklinkum Freiburg, Freiburg im Breisgau

ifi Institut für interdisziplinäre Infektiologie, Hamburg

Universitätsklinik Hamburg-Eppendorf, Hamburg

Med. Hochschule Hannover, Hanover

Universitätsklinikum Heidelberg, Heidelberg

Facharzt für Innere Medizin,, Mannheim

Boehringer Ingelheim Investigational Site, München

Medizinische Poliklinik, München

Klinium Natruper Holz, Osnabrück

Boehringer Ingelheim Investigational Site, Stuttgart

1st Social Insurance Foundation (IKA) Pentelis, Athens

Andreas Syggros Hosp., Athens

Evangelismos Hospital, Athens

"General Hospital G. Gennimatas", Athens

Korgialenio-Benakio-Hellenic Red Cross General Hospital, Athens

Sismanoglio Hospital, Athens

University Hospital of Patras, Pátrai

"Tzanio Hospital", Piraeus

AHEPA Hospital, Thessaloniki

Fondazione S. Raffaele del Monte Tabor, Milan

Ospedale Amedeo di Savoia, Torino

OLVG, Amsterdam

Slotervaart Hospital, Amsterdam

Erasmus Medical Centre, Rotterdam

Medical Centre Haaglanden, The Hague

Hospital Condes Castro Guimarães, Cascais

Hospitais da Universidade de Coimbra, Coimbra

Department of Infeccious Diseases, Lisbon

Hospital de São João, Porto

Universitätsspital Basel, Basel

Kantonsspital St. Gallen, Sankt Gallen

Universitätsspital Zürich, Zurich

Royal Free Hospital, London

SSAT/Crusaid Institute, London

St Mary's Hospital, London

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY